Northwest Biotherapeutics | NWBO - Spese Operative





Spese Operative Cambiamento Data
Agenus USD -221.22M 241.03M 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Celldex Therapeutics USD 456.23M 368.95M 2026-03
Eisai JPY 215.74B 15.84B 2026-03
Merck USD 18.17B 8.01B 2026-03
Northwest Biotherapeutics USD -108.65M 8.26M 2025-09
Pfizer USD 90.1B 77.19B 2026-03
Plus Therapeutics USD 7.11M 1.23M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12